drugset / Trial / NCT00481819
A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation
RandomizedParallel-groupOpen-labelPrevention
Summary
The patients about to undergo kidney transplantation will be randomized to one of the following two group: Group FK506MR: FK506MR/MMF/steroid; Group Prograf® : Prograf® /MMF/steroid. The treatment period is 3 months( 12 weeks)
Timeline
- Start
- 2007-07
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | — | Oral |
| Background | Methylprednisolone | Other / unclassified | — | Oral |
| Background | Mycophenolate Mofetil | Small molecule | — | Oral |
| Background | Prednisolone | Other / unclassified | — | Oral |
Indications
No indication recorded.